Skip to main content
Glama

Statbank Md

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish read-only, idempotent, non-destructive behavior. The description adds substantial behavior beyond that: graceful degradation when LEI/FIGI sources are unavailable, explicit unresolved identifiers, returning figi_candidates on ambiguous matches, and cascading through multiple internal lookup endpoints. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with query patterns and the core directive. The extended detail about cross-source identity, graceful degradation, and ambiguity handling is justified given the tool's complexity, though some parenthetical asides could be tightened.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining what the tool returns. It covers unresolved identifiers, candidate lists on ambiguous matches, source-labelled identifiers, and failure behavior. For a two-type resolver with cascading lookups, this is a complete enough picture for an agent to invoke it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds meaningful value beyond the schema by explaining accepted input forms (ticker, CIK, ISIN, name), providing examples for both company and drug, and warning not to pass full noun phrases like 'NEW YORK ST DORM AUTH revenue bonds' because trailing security-class words will fail the FIGI lookup.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It enumerates supported entity types and the exact identifier outputs (CIK, ticker, LEI, FIGI, RxCUI), which clearly separates it from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID,' which is a strong when-to-use directive. It also gives concrete example queries and internal type-specific guidance. However, it does not explicitly name alternatives or state when not to use this tool beyond the implied name-to-ID scope.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Statbank Md toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Multiple tools have overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical in scope, and the prediction-market tools (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_fill_risk) share similar functions. While some tools are distinct, the boundaries between many are unclear.

Naming Consistency2/5

Names mix product-like identifiers (ask_pipeworx, deep_research), descriptive nouns (entity_profile, subjects), and inconsistent verb forms (query_table, resolve_entity, scan_competitor_ai_presence). No consistent verb_noun pattern is maintained across the set.

Tool Count2/5

With 34 tools, the server is overpopulated relative to its apparent purpose. The name 'Statbank Md' suggests a narrow statistical service, but only 3 tools are Statbank-specific; the rest form a sprawling general-purpose data toolkit. The count is far beyond what the core function needs.

Completeness3/5

For the Statbank subset, the surface is complete (browse subjects, get metadata, query data). As a general data research suite, it covers many domains (SEC, FDA, economics, prediction markets) but lacks execution/trading tools for prediction markets and has no bulk data export or analytics beyond excerpts. Notable gaps exist but many core workflows are covered.

Resources